Recorded €2.3billion profits between April & June
BioNTech, who along with Pfizer, developed the first widely used Covid-19 vaccine, has seen its profits surge in the second quarter of this year.
The German pharmaceutical firm recorded a net profit of over €2.3 billion, between April & June.
In a press release announcing the profits, it is noted that as of 21st July, over one billion doses "of BNT162b2 vaccine were supplied to more than 100 countries or territories worldwide."
The company says profits from the inoculation will help to develop additional drugs against cancer, and other diseases.
We want to make a difference for individuals and humankind. Our strategy remains focused on bringing our broad pipeline of Next-Generation Immunotherapies and #vaccines to people worldwide to address #cancer and a growing list of infectious diseases: https://t.co/CqJHzkeAXa pic.twitter.com/NBE8xvTfUF
— BioNTech SE (@BioNTech_Group) August 9, 2021
12 People Dead After Overnight Russian Attacks On Kyiv
Social Media Could Change Forever If Meta Loses US Legal Battle, Says Experts
Efforts To Achieve Peace Plan For Gaza Continue As US Meet Middle East Mediators
US Military Fire On Ship In Gulf Of Oman
Over 250 People Now Confirmed Dead Following Devastating Earthquake In Colombia
Rescue Operation Continues After 160 Dead In Colombian Earthquake
Six Killed In School Shooting Near Bangkok In Thailand
Reports Of Iran And Oman Working Towards Deal To Reopen Strait Of Hormuz
